Literature DB >> 2041778

Sequences involved in the control of adenovirus L1 alternative RNA splicing.

J P Kreivi1, K Zerivitz, G Akusjärvi.   

Abstract

During an adenovirus infection the expression of mRNA from late region L1 is temporally regulated at the level of alternative 3' splice site selection to produce two major mRNAs encoding the 52,55K and IIIa polypeptides. The proximal 3' splice site (52,55K) is used at all times of the infectious cycle whereas the distal site (IIIa) is used exclusively late after infection. We show that a single A branch nucleotide located at position -23 is used in 52,55K splicing and that two A's located at positions -21 and -22 are used in IIIa splicing. Both 3' splice sites were active in vitro in nuclear extracts prepared from uninfected HeLa cells. However, the efficiency of IIIa splicing was only approximately 10% of 52,55K splicing. This difference in splice site activity correlated with a reduced affinity of the IIIa, relative to the 52,55K, 3' splice site for polypyrimidine tract binding proteins. Reversing the order of 3' splice sites on a tandem pre-mRNA resulted in an almost exclusive IIIa splicing indicating that the order of 3' splice site presentation is important for the outcome of alternative L1 splicing. Based on our results we suggest a cis competition model where the two 3' splice sites compete for a common RNA splicing factor(s). This may represent an important mechanism by which L1 alternative splicing is regulated.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 2041778      PMCID: PMC329446          DOI: 10.1093/nar/19.9.2379

Source DB:  PubMed          Journal:  Nucleic Acids Res        ISSN: 0305-1048            Impact factor:   16.971


  58 in total

1.  The 216-nucleotide intron of the E1A pre-mRNA contains a hairpin structure that permits utilization of unusually distant branch acceptors.

Authors:  K Chebli; R Gattoni; P Schmitt; G Hildwein; J Stevenin
Journal:  Mol Cell Biol       Date:  1989-11       Impact factor: 4.272

2.  Identification, purification, and biochemical characterization of U2 small nuclear ribonucleoprotein auxiliary factor.

Authors:  P D Zamore; M R Green
Journal:  Proc Natl Acad Sci U S A       Date:  1989-12       Impact factor: 11.205

3.  Alternative production of calcitonin and CGRP mRNA is regulated at the calcitonin-specific splice acceptor.

Authors:  R B Emeson; F Hedjran; J M Yeakley; J W Guise; M G Rosenfeld
Journal:  Nature       Date:  1989-09-07       Impact factor: 49.962

4.  The role of the mammalian branchpoint sequence in pre-mRNA splicing.

Authors:  R Reed; T Maniatis
Journal:  Genes Dev       Date:  1988-10       Impact factor: 11.361

Review 5.  Alternative splicing in the control of gene expression.

Authors:  C W Smith; J G Patton; B Nadal-Ginard
Journal:  Annu Rev Genet       Date:  1989       Impact factor: 16.830

6.  Mammalian U2 snRNP has a sequence-specific RNA-binding activity.

Authors:  K K Nelson; M R Green
Journal:  Genes Dev       Date:  1989-10       Impact factor: 11.361

7.  A compensatory base change in human U2 snRNA can suppress a branch site mutation.

Authors:  Y Zhuang; A M Weiner
Journal:  Genes Dev       Date:  1989-10       Impact factor: 11.361

8.  A new species of virus-coded low molecular weight RNA from cells infected with adenovirus type 2.

Authors:  H Söderlund; U Pettersson; B Vennström; L Philipson; M B Mathews
Journal:  Cell       Date:  1976-04       Impact factor: 41.582

9.  Mammalian pre-mRNA branch site selection by U2 snRNP involves base pairing.

Authors:  J Wu; J L Manley
Journal:  Genes Dev       Date:  1989-10       Impact factor: 11.361

10.  cis-acting elements and a trans-acting factor affecting alternative splicing of adenovirus L1 transcripts.

Authors:  C Delsert; N Morin; D F Klessig
Journal:  Mol Cell Biol       Date:  1989-10       Impact factor: 4.272

View more
  11 in total

1.  A novel type of splicing enhancer regulating adenovirus pre-mRNA splicing.

Authors:  O Mühlemann; B G Yue; S Petersen-Mahrt; G Akusjärvi
Journal:  Mol Cell Biol       Date:  2000-04       Impact factor: 4.272

2.  A U1 snRNA binding site improves the efficiency of in vitro pre-mRNA splicing.

Authors:  J P Kreivi; K Zerivitz; K Zefrivitz; G Akusjärvi
Journal:  Nucleic Acids Res       Date:  1991-12-25       Impact factor: 16.971

3.  The molecular defect of ferrochelatase in a patient with erythropoietic protoporphyria.

Authors:  Y Nakahashi; H Fujita; S Taketani; N Ishida; A Kappas; S Sassa
Journal:  Proc Natl Acad Sci U S A       Date:  1992-01-01       Impact factor: 11.205

4.  Control of adenovirus early gene expression during the late phase of infection.

Authors:  S P Fessler; C S Young
Journal:  J Virol       Date:  1998-05       Impact factor: 5.103

5.  Regulation of adenovirus alternative RNA splicing at the level of commitment complex formation.

Authors:  J P Kreivi; G Akusjärvi
Journal:  Nucleic Acids Res       Date:  1994-02-11       Impact factor: 16.971

6.  Functional coexpression of serine protein kinase SRPK1 and its substrate ASF/SF2 in Escherichia coli.

Authors:  B G Yue; P Ajuh; G Akusjärvi; A I Lamond; J P Kreivi
Journal:  Nucleic Acids Res       Date:  2000-03-01       Impact factor: 16.971

7.  Utilization of the bovine papillomavirus type 1 late-stage-specific nucleotide 3605 3' splice site is modulated by a novel exonic bipartite regulator but not by an intronic purine-rich element.

Authors:  Z M Zheng; E S Reid; C C Baker
Journal:  J Virol       Date:  2000-11       Impact factor: 5.103

8.  Selection of the bovine papillomavirus type 1 nucleotide 3225 3' splice site is regulated through an exonic splicing enhancer and its juxtaposed exonic splicing suppressor.

Authors:  Z M Zheng; P He; C C Baker
Journal:  J Virol       Date:  1996-07       Impact factor: 5.103

9.  Evidence for a HeLa cell splicing activity that is necessary for activation of a regulated adenovirus 3' splice site.

Authors:  K Zerivitz; J P Kreivi; G Akusjärvi
Journal:  Nucleic Acids Res       Date:  1992-08-11       Impact factor: 16.971

10.  Sex-lethal autoregulation requires multiple cis-acting elements upstream and downstream of the male exon and appears to depend largely on controlling the use of the male exon 5' splice site.

Authors:  J I Horabin; P Schedl
Journal:  Mol Cell Biol       Date:  1993-12       Impact factor: 4.272

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.